Richard Blumenthal sold Aimmune Therapeutics Inc (AIMT-Nasdaq) - Stock - Brisbane, (CA) (CA)
Richard Blumenthal (D-CT), a U.S. Senator, has disclosed 8 trades in Aimmune Therapeutics Inc (AIMT-Nasdaq) - Stock - Brisbane, (CA) (CA) since 2018, 2 purchases and 6 sales, worth an estimated $480K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Richard Blumenthal sold $1,001 - $15,000 of Aimmune Therapeutics Inc (AIMT-Nasdaq) - Stock - Brisbane, (CA) (CA) on December 5, 2018. Since that trade, CA is up +6.59% against the S&P 500 up +202.72%, an outperformance of -196.13%.
Across these filings, Richard Blumenthal has been a net seller of CA (a buy-to-sell ratio of 0.33). The most recent disclosed CA transaction shown was dated November 15, 2019. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Richard Blumenthal's CA trades vs the price
CA is up +6.59% since Richard Blumenthal sold on December 5, 2018, versus +202.72% for the S&P 500.
Performance since this trade
All Richard Blumenthal CA trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Richard Blumenthal & CA trading FAQ
Is it legal for Richard Blumenthal to trade Aimmune Therapeutics Inc (AIMT-Nasdaq) - Stock - Brisbane, (CA) (CA) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Aimmune Therapeutics Inc (AIMT-Nasdaq) - Stock - Brisbane, (CA) (CA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Richard Blumenthal sell CA?
Richard Blumenthal disclosed a sale of $1,001 - $15,000 of Aimmune Therapeutics Inc (AIMT-Nasdaq) - Stock - Brisbane, (CA) (CA) on December 5, 2018, according to public STOCK Act filings.
How has CA performed since Richard Blumenthal's trade?
Since Richard Blumenthal sold CA on December 5, 2018, the stock is up +6.59%, versus +202.72% for the S&P 500 over the same period, an outperformance of -196.13%.
How many times has Richard Blumenthal traded CA?
Richard Blumenthal has disclosed 8 CA trades since 2018 (2 purchases and 6 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CA trades?
Quantellect tracks every disclosed congressional trade in Aimmune Therapeutics Inc (AIMT-Nasdaq) - Stock - Brisbane, (CA) (CA) on the Aimmune Therapeutics Inc (AIMT-Nasdaq) - Stock - Brisbane, (CA) congressional trading page, which aggregates filings across all members of Congress.
Richard Blumenthal's CA tradesAll congressional filings for Aimmune Therapeutics Inc (AIMT-Nasdaq) - Stock - Brisbane, (CA)Richard Blumenthal's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.